NIH Funding Secured for Preclinical Development of Novel Antibiotic CRS3123

Apr 27, 2020 | Press Releases

Crestone, Inc. Secures NIH Funding for Preclinical Development of Novel Antibiotic CRS3123 to Treat H. pylori Infections.

Learn More:

https://www.businesswire.com/news/home/20200427005005/en/Crestone-Boulder-Colorado-Secures-NIH-Funding-Preclinical